Use of 18F-FDG PET CT for Evaluation of Rarely Seen Adenocarcinoma of Cervix Uteri Before and After Therapy

被引:0
|
作者
Esra Arslan
Özge Vural Topuz
Meftune Özhan
Özgül Ekmekçioğlu
Mehmet Deniz Altıparmak
Kerim Sönmezoğlu
机构
[1] University of Health Sciences,Department of Nuclear Medicine
[2] Istanbul Training and Research Hospital,Department of Nuclear Medicine
[3] Başakşehir Cam and Sakura City Hospital,Department of Nuclear Medicine
[4] Kartal Kosuyolu High Speciality Educational and Research Hospital,Department of Nuclear Medicine
[5] Istanbul Sisli Hamidiye Etfal Training and Research Hospital,Department of Obstetrics and Gynocology
[6] Demiroglu Science University,Department of Nuclear Medicine, Cerrahpasa Medical School
[7] Istanbul Florence Nightingale Hospital,undefined
[8] Istanbul University-Cerrahpasa,undefined
来源
关键词
Adenocarcinoma; Cervix uteri; 18F-FDG PET CT;
D O I
暂无
中图分类号
学科分类号
摘要
Adenocarcinoma is the second most frequent (%15–20) cervical carcinoma, following squamous cell carcinoma (%80) (Fujiwara et al. in Curr Oncol Rep 16:416, 2014 Dec). Other rare type of cancers can occur in cervix, such as adenosquamous, small cell, lymphomas and sarcomas. Here, we present the 44-year-old woman diagnosed with usual type of cervix adenocarcinoma with low FDG uptake, staged and followed up with 18F-FDG PET CT.
引用
收藏
相关论文
共 50 条
  • [41] 18F-FDG PET/CT utility in pancreatic adenocarcinoma; A Comprehensive Review
    Rodriguez-Santiago, Stephanie
    Savir-Baruch, Bital
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [42] Case report: 18F-FDG PET/CT in pulmonary enteric adenocarcinoma
    Luo, Zhe-Huang
    Luo, Xiao-Yan
    Luo, Xiu-Qin
    Jin, Ai-Fang
    Zeng, Qing-Yun
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [43] Clear Cell Adenocarcinoma of the Urethra 18F-FDG PET/CT Imaging
    Nguyen, Ba D.
    CLINICAL NUCLEAR MEDICINE, 2015, 40 (03) : 241 - 243
  • [44] Effect of COVID-19 on 18F-FDG PET/CT: Is There a Need to Consider COVID-19 Status Before Planning 18F-FDG PET/CT for Oncologic Evaluation?
    Kavanal, Anwin Joseph
    Jena, Santosh Ranjan
    Kumar, Rajender
    Das, Chandan Krushna
    Kumar, Sunil
    Mittal, Bhagwant Rai
    JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY, 2021, 49 (03) : 284 - 285
  • [45] The Performance of 18F-FDG PET and 18F-FDG PET/CT in Detection of Carcinoma of Unknown Primary
    Dong, M.
    Zhao, K.
    Zhao, J.
    Guan, Y.
    Liu, Z.
    Ruan, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S275 - S275
  • [46] Role of 18F-FDG PET/CT in detection of recurrence in patients with carcinoma cervix
    Jeph, S.
    Shamim, S. A.
    Sharma, P.
    Kumar, A.
    Tumma, R.
    Jain, N.
    Aggarwal, B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S168 - S168
  • [47] 18F-FDG PET/MRI versus 18F-FDG PET/CT for the diagnosis of pituitary adenoma
    Wang, Hao
    Zhao, Xiaobin
    Zang, Jie
    Zhu, Zhaohui
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [48] Neurolymphomatosis on 18F-FDG PET/CT Diagnosis and Therapy Response
    Gykiere, Pieterjan
    Jans, Lennart
    Degrieck, Bert
    Goethals, Ingeborg
    CLINICAL NUCLEAR MEDICINE, 2016, 41 (02) : 142 - 143
  • [49] Evaluation of liver metastases after radiofrequency ablation:: Utility of 18F-FDG PET and PET/CT
    Barker, DW
    Zagoria, RJ
    Morton, KA
    Kavanagh, PV
    Shen, P
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2005, 184 (04) : 1096 - 1102
  • [50] 18F-FDG PET/CT and CT angiography in the evaluation of immunosuppressive therapy in large vessel vasculitis
    Moragas, M. M. S.
    Andreu, M.
    Martin, J.
    Caresia, A.
    Monteagudo, M.
    Diaz, C.
    Rodriguez, A.
    Bravo, Z.
    Berna, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S465 - S465